ArticleRheumatology and therapy2026

Long-Term Safety and Efficacy of Upadacitinib in Patients with Psoriatic Arthritis: 5-Year Results from the Phase 3 SELECT-PsA 1 Study.

Iain B McInnes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.